News in other languages: Amoéba

10-30	Amoéba : Amoéba annonce la mise à disposition de son rapport financier semestriel au 30 juin 2026
10-27	Amoéba : Amoéba annonce le succès de son augmentation de capital ouverte à tous d’un montant de 9,7 M EUR
10-20	Amoéba : Rappel sur les BSA attachés dans le cadre de l’augmentation de capital par émission d’ABSA ouverte à tous
10-19	Amoéba : Amoéba rappelle les principales modalités de son augmentation de capital ouverte à tous
10-02	Amoéba : Amoéba organise un webinaire le 7 octobre 2026 à 18h00 pour présenter son augmentation de capital ouverte à tous

More news

Managers and Directors: Amoéba

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	2023-12-13
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	2018-08-31
Jean-Baptiste Eberst LAW	General Counsel	-	2015-06-30

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	2014-05-31
Benoît Villers CHM	Chairman	70	2023-12-13
Jean-luc Souche BRD	Director/Board Member	70	2023-05-24

More insiders

Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-11-02	€0.2790	+8.98%	656,453
26-10-30	€0.2560	-3.58%	615,644
26-10-29	€0.2655	-1.67%	1,069,569
26-10-28	€0.2700	-6.90%	1,064,053
26-10-27	€0.2900	-0.85%	3,582,113

Real-time Euronext Paris

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.2790EUR

Average target price

1.000EUR

Spread / Average Target

+258.42%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - Amoéba

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Amoéba

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 11:55:00 2026-11-02 EST			5-day change	1st Jan Change
0.2790 ^EUR	+8.98%		-4.62%	-73.63%

10-02	Amoéba Launches EUR10 Million Capital Raise Via Share Issue	MT
09-25	Amoéba S.A. Provides Earnings Guidance for the Year 2030 and for 2032	CI

Market Cap	36.03M 40.36M 33.06M 30.08M 56.39M 3.82B 57.51M 395M 159M 2.02B 151M 148M 6.37B	P/E 2026 *	-3.72x	P/E 2027 *	27.9x
Enterprise Value	47.18M 52.85M 43.3M 39.38M 73.84M 5B 75.31M 517M 208M 2.64B 198M 194M 8.34B	EV / Sales 2026 *	9.25x	EV / Sales 2027 *	3.08x
Free-Float	81.63%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Euronext Paris	ALMIB	Real-time
Börse Stuttgart	A1H	Delayed
Deutsche Boerse AG	A1H	Delayed
Boerse Muenchen	A1H	Real-time

10-02	Amoéba Launches EUR10 Million Capital Raise Via Share Issue	MT
09-25	Amoéba S.A. Provides Earnings Guidance for the Year 2030 and for 2032	CI
09-23	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI

Amoéba Stock

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Valuation: Amoéba

Chart: Amoéba

Latest news: Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Quotes and Performance

Price Extremes

Managers and Directors: Amoéba

Latest insider transactions

Pesticide

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

10-30	Amoéba : Amoéba announces the publication of its half-year financial report as of June 30, 2026	AT
10-27	Amoéba : Amoéba announces the successful completion of its EUR 9.7 million capital increase open to all shareholders	AT
10-20	Amoéba : Reminder regarding the warrants (BSA) attached to the capital increase through the issuance of ABSAs open to all shareholders	AT
10-02	Amoéba : Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch	AT
09-25	Amoéba : Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency	AT

1 day	+8.98%
1 week	-4.62%
Current month	+8.98%
1 month	-11.71%
3 months	-61.03%
6 months	-67.93%
Current year	-73.63%

1 week	0.25	0.3
1 month	0.25	0.35
Current year	0.25	1.12
1 year	0.25	1.12
3 years	0.25	1.44
5 years	0.25	1.6
10 years	0.25	33.8

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/30/26	Benoît Villers	Sell	Chairman	-31,100	0.0400%
5/23/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	40,000	0.0805%
5/22/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	560,000	1.1277%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	+8.98%	-4.62%	-74.17%	-34.89%	36.92M
NUTRIEN LTD.	+1.28%	+2.44%	+28.55%	+29.06%	33.16B
CF INDUSTRIES HOLDINGS, INC.	-2.41%	-0.42%	+44.47%	+49.81%	18.66B
QINGHAI SALT LAKE INDUSTRY CO.,LTD	+0.69%	-1.53%	-11.69%	+32.01%	17.29B
SABIC AGRI-NUTRIENTS COMPANY	+0.35%	+2.70%	-6.78%	-14.52%	14.43B
PHOSAGRO	+0.11%	-.--%	-.--%	-.--%	12.96B
YARA INTERNATIONAL ASA	+0.30%	-2.68%	+7.02%	+7.45%	10.91B
JORDAN PHOSPHATE MINES CO. PLC	-1.53%	-7.55%	-5.76%	+139.53%	9.21B
ACRON	-0.22%	-.--%	-.--%	-.--%	8.3B
CORTEVA, INC.	+2.41%	-0.25%	-	-	7.77B
Average	+1.00%	-1.09%	-2.04%	+23.16%	13.27B
Weighted average by Cap.	+0.17%	-0.45%	+11.98%	+28.82%

	2026 *	2027 *
Net sales	5.1M 5.71M 4.68M 4.26M 7.98M 541M 8.14M 55.9M 22.53M 285M 21.44M 20.98M 902M	15.55M 17.42M 14.27M 12.98M 24.34M 1.65B 24.82M 170M 68.7M 870M 65.37M 63.97M 2.75B
Net income	-5.2M -5.82M -4.77M -4.34M -8.14M -551M -8.3M -56.99M -22.97M -291M -21.86M -21.39M -919M	550K 616K 505K 459K 861K 58.32M 878K 6.03M 2.43M 30.78M 2.31M 2.26M 97.23M
Net Debt	11.15M 12.49M 10.23M 9.31M 17.45M 1.18B 17.8M 122M 49.26M 624M 46.87M 45.87M 1.97B	11.85M 13.27M 10.87M 9.89M 18.55M 1.26B 18.92M 130M 52.35M 663M 49.81M 48.75M 2.09B